留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

TNF-α、IL-6、IL-17在胎膜早破母儿感染相关不良妊娠结局中的表达及临床价值

赵倩 何霞 凌娅 可饶阳 李赛男 黄蓉 祁文瑾

赵倩, 何霞, 凌娅, 可饶阳, 李赛男, 黄蓉, 祁文瑾. TNF-α、IL-6、IL-17在胎膜早破母儿感染相关不良妊娠结局中的表达及临床价值[J]. 昆明医科大学学报, 2021, 42(9): 101-107. doi: 10.12259/j.issn.2095-610X.S20210940
引用本文: 赵倩, 何霞, 凌娅, 可饶阳, 李赛男, 黄蓉, 祁文瑾. TNF-α、IL-6、IL-17在胎膜早破母儿感染相关不良妊娠结局中的表达及临床价值[J]. 昆明医科大学学报, 2021, 42(9): 101-107. doi: 10.12259/j.issn.2095-610X.S20210940
Qian ZHAO, Xia HE, Ya LING, Rao-yang KE, Sai-nan LI, Rong HUANG, Wen-jin QI. The Clinical Value of Detection of TNF-α、IL-6 and IL-17 in Premature Ruptureof Membranes with Adverse Pregnancy Outcomes Associated with Maternal and Fetal Infection[J]. Journal of Kunming Medical University, 2021, 42(9): 101-107. doi: 10.12259/j.issn.2095-610X.S20210940
Citation: Qian ZHAO, Xia HE, Ya LING, Rao-yang KE, Sai-nan LI, Rong HUANG, Wen-jin QI. The Clinical Value of Detection of TNF-α、IL-6 and IL-17 in Premature Ruptureof Membranes with Adverse Pregnancy Outcomes Associated with Maternal and Fetal Infection[J]. Journal of Kunming Medical University, 2021, 42(9): 101-107. doi: 10.12259/j.issn.2095-610X.S20210940

TNF-α、IL-6、IL-17在胎膜早破母儿感染相关不良妊娠结局中的表达及临床价值

doi: 10.12259/j.issn.2095-610X.S20210940
基金项目: 昆明医科大学研究生创新基金资助项目(2020S163);云南省医疗卫生单位内设研究机构科研基金资助项目(2018NS0141)
详细信息
    作者简介:

    赵倩(1995~),女,彝族,云南文山人,医学硕士,住院医师,主要从事妇产科临床研究工作

    通讯作者:

    祁文瑾,E-mail:wenjincookie@163.com

  • 中图分类号: R714.2

The Clinical Value of Detection of TNF-α、IL-6 and IL-17 in Premature Ruptureof Membranes with Adverse Pregnancy Outcomes Associated with Maternal and Fetal Infection

  • 摘要:   目的  探讨母血、脐血血清中TNF-α、IL-6、IL-17表达水平在胎膜早破(premature rupture of membranes,PROM)合并绒毛膜羊膜炎(chorioamnionitis,CS)及PROM新生儿围产期感染中的临床意义。  方法  51例因胎膜早破至昆明医科大学第一附属医院产科住院的孕妇为PROM组,同期20例正常分娩孕妇为对照组。采用ELISA法检测母血、脐血血清TNF-α、IL-6、IL-17水平。再次将PROM组分为PROM无CS组和PROM合并CS组,PROM无新生儿围产期感染组(A1)和PROM新生儿围产期感染组(A2);比较母血、脐血中3项指标在不同分组中的表达水平,ROC曲线分析三项指标预测胎膜早破母儿感染相关不良妊娠结局的价值。  结果  (1)PROM合并CS组母血、脐血血清TNF-α、IL-6表达水平显著高于PROM无CS组和对照组(P < 0.05);PROM无CS组母血TNF-α、脐血IL-6的表达水平显著高于对照组(P < 0.05);(2)A2组母血、脐血血清TNF-α、IL-6和IL-17表达水平均显著高于A1组和对照组(P < 0.05);A1组母血TNF-α、脐血IL-6的表达水平显著高于对照组(P < 0.05);(3)母血、脐血血清TNF-α、IL-6、IL-17表达水平互呈显著正相关(P < 0.001);(4)诊断PROM合并CS时,单项检测母血TNF-α的曲线下面积(Area under the curve,AUC)最大(0.763),母血TNF-α的AUC高于脐血TNF-α(0.614)(P < 0.05);联合母血+脐血TNF-α+IL-6 4项指标诊断PROM合并CS的AUC(0.820)显著高于脐血TNF-α单项指标的AUC值(0.614)(P < 0.05);(5)诊断PROM新生儿围产期感染时,单项检测时母血中IL-6的AUC最大(0.800),脐血中IL-17的AUC最大(0.829),脐血IL-17的AUC高于母血IL-17(0.735)(P < 0.05);联合脐血IL-6+IL-17 2项指标或联合脐血TNF-α+ IL-6+ IL-17 3项指标诊断PROM发生新生儿围产期感染的诊断效果较好(AUC:0.863、0.866)。  结论  母血、脐血TNF-α、IL-6、IL-17是预测PROM母儿感染相关不良妊娠结局的重要指标,联合检测效果较好。临床工作中若考虑脐血检测的局限性,仅检测母血以上细因子也有较好的临床运用价值。
  • 图  1  母血、脐血TNF-α、IL-6诊断PROM合并CS的ROC曲线

    A:单项检测;B:联合检测。

    Figure  1.  ROC curve of TNF-α and IL-6 in maternal serum and umbilical cord serum in the diagnosis of PROM with CS

    图  2  母血、脐血TNF-α、IL-6和IL-17诊断PROM新生儿围产期感染的ROC曲线

    A:单项检测;B:联合检测。

    Figure  2.  ROC curve of TNF-α,IL-6 and IL-17 in maternal serum and umbilical cord serum in the diagnosis of PROM with neonatal infection during perinatal

    表  1  研究对象临床资料比较($ \bar{x}\pm s $

    Table  1.   Comparation of clinical information between study objects ($ \bar{x}\pm s $

    组别例数产妇
    年龄(岁)
    孕次
    (次)
    孕前BMI
    [kg/m2]
    孕期增重
    (kg)
    入院体温
    (℃)
    Apgar评分($ \bar{x} $ ± s)新生儿脐动脉PH值
    ($ \bar{x} $ ± s)
    1 min5 min
    对照组 20 29.20 ± 4.82 2.45 ± 1.39 20.71 ± 2.25 12.91 ± 3.97 36.78 ± 0.38 8.95 ± 0.22 10 7.25 ± 0.07
    PROM组 51 30.28 ± 3.23 2.02 ± 1.12 21.84 ± 3.26 11.79 ± 3.93 36.61 ± 0.37 9.01 ± 0.45 9.98 ± 0.14 7.26 ± 0.09
    t/Z −0.919 1.354 −1.419 1.069 −1.575 −1.819 −0.623 0.316
    P 0.366 0.180 0.160 0.293 0.120 0.073 0.535 0.753
    下载: 导出CSV

    表  2  对照组、PROM无CS组、PROM合并CS组母血、脐血各因子表达水平比较

    Table  2.   Comparation of various cytokine expression levels in maternal serum and umbilical cord serum between the control group,PROM without CS group and PROM with CS group

    指标
    (ng/L)
    对照组
    n = 20)
    PROM无CS组(n = 33)PROM合并CS(n = 18)χ2P
    母血 TNF-α 17.43(14.32,20.24) 25.40(18.57,41.54)# 48.01(28.19,302.68)#& 24.834 < 0.001
    IL-6 7.00(3.56,12.40) 8.61(5.73,11.91) 15.76(8.41,62.69) #& 10.844 0.004
    IL-17 48.26(32.13,64.69) 52.63(34.93,133.56) 64.99(33.27,265.14) 2.756 0.252
    脐血 TNF-α 17.04(14.02,19.99) 18.25(10.86,39.21) 25.12(14.59,123.18)#& 6.285 0.043
    IL-6 5.35(4.17,8.21) 8.16(5.10,17.26)# 25.37(9.43,39.33)#& 17.908 < 0.001
    IL-17 33.63(17.67,45.82) 38.47(24.09,56.12) 52.93(25.62,122.31) 3.946 0.139
      与对照组相比,#P < 0.05;与PROM无CS组相比,&P < 0.05。
    下载: 导出CSV

    表  3  对照组、A1、A2组母血、脐血各因子表达水平比较

    Table  3.   Comparation of various cytokine expression levels in maternal serum and umbilical cord serum between the control group,A1 group and A1 group

    指标(ng/L)对照组(n = 20)A1组(n = 41)A2组(n = 10)χ2P
    母血 TNF-α 17.43(14.32,20.24) 25.40(18.57,41.54)# 48.01(28.19,302.68)#& 17.468 < 0.001
    IL-6 7.00(3.56,12.40) 8.47(5.65,12.53) 47.56(10.13,148.23)#& 11.475 0.001
    IL-17 48.26(32.13,64.69) 48.45(32.49,108.74) 227.41(45.31,436.34)#& 7.202 0.007
    脐血 TNF-α 17.04(14.02,19.99) 18.98(11.05,32.21) 46.98(16.43,435.71)#& 6.244 0.044
    IL-6 5.35(4.17,8.21) 9.14(5.38,21.64)# 33.51(17.91,94.00)#& 19.852 < 0.001
    IL-17 33.63(17.67,45.82) 38.47(20.66,52.82) 91.02(50.54,365.29)#& 13.208 0.001
      与对照组相比,#P < 0.05;与A1组相比,&P < 0.05。
    下载: 导出CSV

    表  4  各细胞因子在母血、脐血中的相关性分析

    Table  4.   Correlation analysis of each cytokine in maternal serum with it in umbilical cord serum

    项目相关系数rP
    TNF-α(母血/脐血) 0.626 < 0.001*
    IL-6(母血/脐血) 0.646 < 0.001*
    IL-17(母血/脐血) 0.789 < 0.001*
      *P < 0.05。
    下载: 导出CSV

    表  5  母血、脐血TNF-α、IL-6诊断PROM合并CS的ROC曲线

    Table  5.   ROC curve of TNF-α and IL-6 in maternal serum and umbilical cord serum in the diagnosis of PROM with CS

    指标(pg/mL)临界点AUC灵敏度(%)特异度(%)95%置信区间P
    母血 TNF-α 26.19 0.763 83.3 66.7 0.624~0.871 < 0.001
    IL-6 12.32 0.702 61.1 81.8 0.558~0.822 0.013
    TNF-α+ IL-6 0.747 77.8 66.7 0.606~0.859 0.005
    脐血 TNF-α 13.52 0.614 83.3 39.4 0.468~0.747 0.1697
    IL-6 11.59 0.673 72.2 66.7 0.528~0.798 0.027
    TNF-α+ IL-6 0.628 96.4 36.4 0.481~0.759 0.115
    母血+脐血 TNF-α+ IL-6 0.820 72.2 87.9 0.687~0.913 0.005
    下载: 导出CSV

    表  6  母血、脐血TNF-α、IL-6和IL-17诊断PROM发生新生儿围产期感染的ROC曲线

    Table  6.   ROC curve of TNF-α,IL-6 and IL-17 in maternal serum and umbilical cord serum in the diagnosis of PROM with CS

    指标(pg/mL)临界点AUC灵敏度(%)特异度(%)95%置信区间P
    母血 TNF-α 26.19 0.787 90.0 56.1 0.649~0.889 < 0.001
    IL-6 8.75 0.800 100 51.2 0.664~0.899 < 0.001
    IL-17 179.57 0.735 60.0 85.4 0.593~0.849 0.014
    TNF-α+ IL-6 0.810 100.0 51.2 0.675~0.906 < 0.001
    TNF-α+ IL-6+ IL-17 0.766 90.0 61.0 0.626~0.873 0.007
    脐血 TNF-α 13.52 0.722 100.0 39.0 0.579~0.838 0.015
    IL-6 14.18 0.795 90 65.9 0.659~0.895 < 0.001
    IL-17 53.00 0.829 80.0 78.0 0.698~0.920 < 0.001
    IL-6+ IL-17 0.863 100.0 65.9 0.738~0.943 < 0.001
    TNF-α+ IL-6+ IL-17 0.866 90.00 80.49 0.741~0.945 < 0.001
    母血 + 脐血 TNF-α+ IL-6 +IL-17 0.822 90.0 75.6 0.689~0.915 < 0.001
    下载: 导出CSV
  • [1] Bond D M,Middleton P,Levett K M,et al. Planned early birth versus expectant management for women with preterm prelabour rupture of membranes prior to 37 weeks' gestation for improving pregnancy outcome[J]. Cochrane Database Syst Rev,2017,3(3):CD004735.
    [2] Middleton P,Shepherd E,Flenady V,et al. Planned early birth versus expectant management(waiting)for prelabour rupture of membranes at term(37 weeks or more)[J]. Cochrane Database Syst Rev,2017,1(1):CD005302.
    [3] Yoneyama Y,Suzuki S,Sawa R,et al. Changes in the proportion of T helper 1 and T helper 2 cells in cord blood after premature rupture of membranes[J]. Archives of gynecology and obstetrics,2003,267(4):217-220. doi: 10.1007/s00404-002-0324-5
    [4] 周美茜,蔡畅,董磊,等. 胎膜早破外周血单个核细胞Th1/Th2免疫偏移的临床研究[J]. 中华医院感染学杂志,2012,22(08):1557-1560.
    [5] 谢幸, 孔北华, 段涛. 妇产科学[M]. 第九版. 北京: 人民卫生出版社, 2018: 154-155.
    [6] 陈忠年. 妇产科病理学[M]. 上海: 上海医科大学出版社, 1996: 341-245
    [7] 邵肖梅, 叶鸿瑁, 丘小汕. 实用新生儿学[M]. 第5版. 北京: 人民卫生出版社, 2019: 510-622.
    [8] Fortunato S,Menon R,Bryant C,et al. Programmed cell death(apoptosis)as a possible pathway to metalloproteinase activation and fetal membrane degradation in premature rupture of membranes[J]. American Journal of Obstetrics and Gynecology,2000,182(6):1468-1476. doi: 10.1067/mob.2000.107330
    [9] Menon R,Fortunato S. Infection and the role of inflammation in preterm premature rupture of the membranes[J]. Best Practice & Research. Clinical Obstetrics & Gynaecology,2007,21(3):467-478.
    [10] Menon R,Lombardi S,Fortunato S. TNF-alpha promotes caspase activation and apoptosis in human fetal membranes[J]. Journal of Assisted Reproduction and Genetics,2002,19(4):201-204. doi: 10.1023/A:1014898130008
    [11] Fortunato S,Menon R,Lombardi S. Role of tumor necrosis factor-alpha in the premature rupture of membranes and preterm labor pathways[J]. American Journal of Obstetrics and Gynecology,2002,187(5):1159-1162. doi: 10.1067/mob.2002.127457
    [12] Martinez-Varea A,Romero R,Xu Y,et al. Clinical chorioamnionitis at term VII:The amniotic fluid cellular immune response[J]. Journal of Perinatal Medicine,2017,45(5):523-538.
    [13] Galaz J,Romero R,Slutsky R,et al. Cellular immune responses in amniotic fluid of women with preterm prelabor rupture of membranes[J]. Journal of Perinatal Medicine,2020,48(3):222-233. doi: 10.1515/jpm-2019-0395
    [14] Ito M,Nakashima A,Hidaka T,et al. A role for IL-17 in induction of an inflammation at the fetomaternal interface in preterm labour[J]. Journal of Reproductive Immunology,2010,84(1):75-85. doi: 10.1016/j.jri.2009.09.005
    [15] Cobo T,Kacerovsky M,Palacio M,et al. Intra-amniotic inflammatory response in subgroups of women with preterm prelabor rupture of the membranes[J]. PloS One,2012,7(8):e43677. doi: 10.1371/journal.pone.0043677
    [16] Onishi R,Gaffen S. Interleukin-17 and its target genes:mechanisms of interleukin-17 function in disease[J]. Immunology,2010,129(3):311-321. doi: 10.1111/j.1365-2567.2009.03240.x
    [17] Rito D,Viehl L,Buchanan P,et al. Augmented Th17-type immune responses in preterm neonates exposed to histologic chorioamnionitis[J]. Pediatric Research,2017,81(4):639-645. doi: 10.1038/pr.2016.254
  • [1] 王雨涛, 柳娟.  慢性肾脏病患者血清IL-6、Cys C、TNF-α与肌肉减少症的关系及对患者死亡风险的影响, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20241013
    [2] 赵琨, 肖云, 杨纯, 严志凌, 董敏娜, 向柄全, 肖茗耀.  白细胞介素-4在脂多糖诱导急性肺损伤模型中的保护作用, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20220805
    [3] 李赛男, 祁文瑾, 可绕阳, 黄蓉, 杨光琼.  MMPs和SAA在未足月胎膜早破发病机制中的作用, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20220905
    [4] 郭珊珊, 刘继红.  妊娠期阴道菌群变化与胎膜早破的相关性, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20211107
    [5] 张莉, 余丹, 王雨婷, 苟志梅, 杨仁华, 何波, 沈志强, 柴文英, 陈鹏.  灯盏乙素对OX-LDL损伤的RAW264.7细胞中PKC和TNF-α表达的影响, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20211040
    [6] 李凌洁, 苏静, 高海霞, 王沛沛, 席作明, 张广霞.  颊粘膜含化米索前列醇在足月胎膜早破孕妇促宫颈成熟中的应用, 昆明医科大学学报.
    [7] 冯梓乔, 张云桥, 游旭, 张闻宇, 龙青, 滕兆伟, 曾勇.  IL-6在精神分裂症中的研究进展, 昆明医科大学学报.
    [8] 曾怡, 杨敏, 廖云娟, 何振坤, 连希艳.  多靶点治疗IV+V型狼疮肾炎的临床疗效及对血清白细胞介素水平的作用评价, 昆明医科大学学报.
    [9] 白润爱.  疏血通对急性脑梗患者脑血流动力学、血清sICAM-1、IL-6、TNF-α的影响, 昆明医科大学学报.
    [10] 李慧.  产前感染与胎膜早破相关性分析, 昆明医科大学学报.
    [11] 黄柯冰.  舒芬太尼与咪唑安定对行脑动脉瘤栓塞术患者麻醉效果比较, 昆明医科大学学报.
    [12] 马维江.  伯氏疏螺旋体BmpA诱导的莱姆关节炎中白细胞介素-6的变化, 昆明医科大学学报.
    [13] 马承斌.  白细胞介素-6和C反应蛋白水平在人工关节置换术前后的临床意义, 昆明医科大学学报.
    [14] 阿永俊.  肝衰竭患者MARS人工肝治疗前后不同疗效组外周血TNF-αmRNA和IL-6 mRNA的表达, 昆明医科大学学报.
    [15] 杜海莲.  慢性阻塞性肺疾病患者血清IL-17、IL-6、IL-8、CRP、TNF-α的变化及其相关性, 昆明医科大学学报.
    [16] 张立亚.  竖直矫治对倾倒磨牙龈沟液中白细胞介素-1β,白细胞介素-6及白细胞介素-8水平的影响, 昆明医科大学学报.
    [17] 曹蕊.  瘦素对动脉粥样硬化血管内皮细胞中IL-6表达的影响, 昆明医科大学学报.
    [18] 翟宇强.  膀胱癌组织中白细胞介素-12B 基因启动子区甲基化的变化及其意义, 昆明医科大学学报.
    [19] 徐盈.  脓毒症大鼠肿瘤坏死因子-a、内皮素-1、核因子kB表达与心肌损伤及药物影响的研究, 昆明医科大学学报.
    [20] 谭琳.  重组人白细胞介素-11减轻初发急性白血病诱导化疗后血小板减少的作用观察, 昆明医科大学学报.
  • 加载中
图(2) / 表(6)
计量
  • 文章访问数:  4316
  • HTML全文浏览量:  2501
  • PDF下载量:  13
  • 被引次数: 0
出版历程
  • 收稿日期:  2021-07-05
  • 网络出版日期:  2021-09-09
  • 刊出日期:  2021-09-30

目录

    /

    返回文章
    返回